MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 341041 | Name: SC-40827

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SC-40827, also known as Collagenase inhibitor CI-2, is a Collagenase inhibitor.

Chemical Structure

SC-40827
SC-40827
CAS#101470-42-2

Theoretical Analysis

MedKoo Cat#: 341041

Name: SC-40827

CAS#: 101470-42-2

Chemical Formula: C29H40N4O6

Exact Mass: 540.2948

Molecular Weight: 540.66

Elemental Analysis: C, 64.42; H, 7.46; N, 10.36; O, 17.75

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Collagenase inhibitor CI-2; SC-40827; SC 40827; SC40827;
IUPAC/Chemical Name
L-Tyrosinamide, N-(1-carboxy-3-((phenylacetyl)amino)propyl)-L-leucyl-N,O-dimethyl-, (S)-
InChi Key
WGPZWVCUEAOMHN-SDHOMARFSA-N
InChi Code
InChI=1S/C29H40N4O6/c1-19(2)16-24(28(36)33(3)25(27(30)35)17-21-10-12-22(39-4)13-11-21)32-23(29(37)38)14-15-31-26(34)18-20-8-6-5-7-9-20/h5-13,19,23-25,32H,14-18H2,1-4H3,(H2,30,35)(H,31,34)(H,37,38)/t23-,24-,25-/m0/s1
SMILES Code
O=C(N)[C@H](CC1=CC=C(OC)C=C1)N(C([C@H](CC(C)C)N[C@H](C(O)=O)CCNC(CC2=CC=CC=C2)=O)=O)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 540.66 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lahdentausta L, Leskelä J, Winkelmann A, Tervahartiala T, Sorsa T, Pesonen E, Pussinen PJ. Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence. J Cardiovasc Transl Res. 2018 Jan 18. doi: 10.1007/s12265-018-9789-x. [Epub ahead of print] PubMed PMID: 29349668. 2: Wills B, Cardona AF, Rojas L, Ruiz-Patiño A, Arrieta O, Reguart N, Carranza H, Vargas C, Otero J, Corrales L, Martín C, Cuello M, Pino LE, Rolfo C, Rosell R, Zatarain-Barrón ZL; Latin-American Consortium for the Investigation of Lung Cancer (CLICaP). Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab. Anticancer Res. 2017 Nov;37(11):6429-6436. PubMed PMID: 29061829. 3: Mechmeche R, Zaroui A, Aloui S, Boukhris M, Allal-Elasmi M, Kaabachi N, Zouari B. Late mitral restenosis after percutaneous commissurotomy: Predictive value of inflammation and extracellular matrix remodeling biomarkers. Heart Lung. 2017 Jul - Aug;46(4):258-264. doi: 10.1016/j.hrtlng.2017.03.006. Epub 2017 Apr 24. PubMed PMID: 28450150. 4: Martines A, Stifanese R, Faelli EL, Perasso L, Melloni I, Ruggeri P, Averna M. Calpain-1 resident in lipid raft/caveolin-1 membrane microdomains plays a protective role in endothelial cells. Biochimie. 2017 Feb;133:20-27. doi: 10.1016/j.biochi.2016.12.002. Epub 2016 Dec 9. PubMed PMID: 27956030. 5: Liu HY, Gu WJ, Wang CZ, Ji XJ, Mu YM. Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials. Medicine (Baltimore). 2016 Jun;95(24):e3904. doi: 10.1097/MD.0000000000003904. Review. PubMed PMID: 27310993; PubMed Central PMCID: PMC4998479. 6: Chen YC, Ho WM, Lee YS, Chen HW, Chen CM. Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population. PLoS One. 2015 Nov 9;10(11):e0142482. doi: 10.1371/journal.pone.0142482. eCollection 2015. PubMed PMID: 26551785; PubMed Central PMCID: PMC4638341. 7: Spindler KL, Christensen IJ, Nielsen HJ, Jakobsen A, Brünner N. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer. Tumour Biol. 2015 Jun;36(6):4301-8. doi: 10.1007/s13277-015-3069-z. Epub 2015 Jan 23. PubMed PMID: 25608838. 8: Levine JM, Cohen ND, Heller M, Fajt VR, Levine GJ, Kerwin SC, Trivedi AA, Fandel TM, Werb Z, Modestino A, Noble-Haeusslein LJ. Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs. PLoS One. 2014 May 1;9(5):e96408. doi: 10.1371/journal.pone.0096408. eCollection 2014. PubMed PMID: 24788791; PubMed Central PMCID: PMC4006832. 9: Devereux G, Steele S, Jagelman T, Fielding S, Muirhead R, Brady J, Grierson C, Brooker R, Winter J, Fardon T, McCormick J, Huang JT, Miller D. An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis. J Cyst Fibros. 2014 Sep;13(5):557-63. doi: 10.1016/j.jcf.2014.01.010. Epub 2014 Feb 11. PubMed PMID: 24525080. 10: Roine I, Pelkonen T, Bernardino L, Lauhio A, Tervahartiala T, Lappalainen M, Kataja M, Pitkäranta A, Sorsa T, Peltola H. Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis. Pediatr Infect Dis J. 2014 Jul;33(7):675-9. doi: 10.1097/INF.0000000000000249. PubMed PMID: 24445831. 11: Braicu EI, Gasimli K, Richter R, Nassir M, Kümmel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A, Mentze M, Fotopoulou C, Pop C, Lichtenegger W, Sehouli J; Tumor Bank Ovarian Cancer (TOC); German North Eastern Society for Gynecological Oncology (NOGGO). Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial. Anticancer Res. 2014 Jan;34(1):385-91. PubMed PMID: 24403492. 12: de Mendonça MR, Rizzi LG, Contessoto V, Leite VB, Alves NA. Inferring a weighted elastic network from partial unfolding with coarse-grained simulations. Proteins. 2014 Jan;82(1):119-29. doi: 10.1002/prot.24381. Epub 2013 Sep 10. PubMed PMID: 23900877. 13: Ortak H, Demir S, Ateş O, Söğüt E, Alim S, Benli I. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion. Exp Eye Res. 2013 Aug;113:151-5. doi: 10.1016/j.exer.2013.06.009. Epub 2013 Jun 18. PubMed PMID: 23791966. 14: Averna M, Pedrazzi M, Minicucci L, De Tullio R, Cresta F, Salamino F, Pontremoli S, Melloni E. Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. PLoS One. 2013 Jun 13;8(6):e66089. doi: 10.1371/journal.pone.0066089. Print 2013. PubMed PMID: 23785472; PubMed Central PMCID: PMC3681946. 15: Suárez-Zarracina T, Valle-Garay E, Collazos J, Montes AH, Cárcaba V, Carton JA, Asensi V. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients. J Viral Hepat. 2012 Oct;19(10):685-93. doi: 10.1111/j.1365-2893.2012.01596.x. Epub 2012 Mar 15. PubMed PMID: 22967099. 16: Velagaleti RS, Gona P, Sundström J, Larson MG, Siwik D, Colucci WS, Benjamin EJ, Vasan RS. Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality. Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2283-8. doi: 10.1161/ATVBAHA.110.208462. Epub 2010 Aug 26. PubMed PMID: 20798380; PubMed Central PMCID: PMC2959140. 17: Montes AH, Valle-Garay E, Alvarez V, Pevida M, García Pérez E, Paz J, Meana A, Asensi V. A functional polymorphism in MMP1 could influence osteomyelitis development. J Bone Miner Res. 2010 Apr;25(4):912-9. doi: 10.1359/jbmr.091013. PubMed PMID: 19821768. 18: Frantz S, Störk S, Michels K, Eigenthaler M, Ertl G, Bauersachs J, Angermann CE. Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality. Eur J Heart Fail. 2008 Apr;10(4):388-95. doi: 10.1016/j.ejheart.2008.02.015. Epub 2008 Mar 17. PubMed PMID: 18343723. 19: Sørensen NM, Byström P, Christensen IJ, Berglund A, Nielsen HJ, Brünner N, Glimelius B. TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid. Clin Cancer Res. 2007 Jul 15;13(14):4117-22. PubMed PMID: 17634538. 20: Vairaktaris E, Yapijakis C, Yiannopoulos A, Vassiliou S, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Critselis E, Avgoustidis D, Neukam FW, Patsouris E. Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep. 2007 Apr;17(4):963-8. PubMed PMID: 17342343.

View History

SC-III3

SC-III3